Evidence map›Paper›PMID 34758829›Full record

ArticleJournal of nanobiotechnology2021

Tea polyphenol modified, photothermal responsive and ROS generative black phosphorus quantum dots as nanoplatforms for promoting MRSA infected wounds healing in diabetic rats.

Shibo Xu, Linna Chang, Yanan Hu, Xingjun Zhao, Shuocheng Huang, Zhenhua Chen, Xiuli Ren, Xifan Mei

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Journal of nanobiotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 87 citations in OpenAlex.

  1. Adaptive Quantum Dot Biointerfaces for Precision Wound Repair.Nanomaterials (Basel, Switzerland) · 2026
    Review
  2. Review
  3. Biofilm-Responsive Nanoplatforms for Infected Wound Reconstruction.International journal of nanomedicine · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Shibo XuJinzhou Medical University, Jinzhou, 121001, Liaoning, China.
Linna ChangJinzhou Medical University, Jinzhou, 121001, Liaoning, China.
Yanan HuJinzhou Medical University, Jinzhou, 121001, Liaoning, China.
Xingjun ZhaoJinzhou Medical University, Jinzhou, 121001, Liaoning, China.
Shuocheng HuangJinzhou Medical University, Jinzhou, 121001, Liaoning, China.
Zhenhua ChenJinzhou Medical University, Jinzhou, 121001, Liaoning, China. zhchen561@yahoo.com.ORCID http://orcid.org/0000-0002-0161-0236
Xiuli RenJinzhou Medical University, Jinzhou, 121001, Liaoning, China. rxlrenxiuli@163.com.
Xifan MeiJinzhou Medical University, Jinzhou, 121001, Liaoning, China. meixifan1971@163.com.
Jinzhou Medical University · CN

Funding

National Natural Science Foundation of China 81771987National Natural Science Foundation of China 82072076
6 · The paper itself

Abstract

backgroundHealing of MRSA (methicillin-resistant Staphylococcus aureus) infected deep burn wounds (MIDBW) in diabetic patients remains an obstacle but is a cutting-edge research problem in clinical science. Surgical debridement and continuous antibiotic use remain the primary clinical treatment for MIDBW. However, suboptimal pharmacokinetics and high doses of antibiotics often cause serious side effects such as fatal complications of drug-resistant bacterial infections. MRSA, which causes wound infection, is currently a bacterium of concern in diabetic wound healing. In more severe cases, it can even lead to amputation of the patient's limb. The development of bioactive nanomaterials that can promote infected wound healing is significant.

resultsThe present work proposed a strategy of using EGCG (Epigallocatechin gallate) modified black phosphorus quantum dots (BPQDs) as therapeutic nanoplatforms for MIDBW to achieve the synergistic functions of NIR (near-infrared)-response, ROS-generation, sterilization, and promoting wound healing. The electron spin resonance results revealed that EGCG-BPQDs@H had a more vital photocatalytic ability to produce singlet oxygen than BPQDs@H. The inhibition results indicated an effective bactericidal rate of 88.6% against MRSA. Molecular biology analysis demonstrated that EGCG-BPQDs significantly upregulated CD31 nearly fourfold and basic fibroblast growth factor (bFGF) nearly twofold, which were beneficial for promoting the proliferation of vascular endothelial cells and skin epidermal cells. Under NIR irradiation, EGCG-BPQDs hydrogel (EGCG-BPQDs@H) treated MIDBW area could rapidly raise temperature up to 55 °C for sterilization. The MIBDW closure rate of rats after 21 days of treatment was 92.4%, much better than that of 61.1% of the control group. The engineered EGCG-BPQDs@H were found to promote MIDBW healing by triggering the PI3K/AKT and ERK1/2 signaling pathways, which could enhance cell proliferation and differentiation. In addition, intravenous circulation experiment showed good biocompatibility of EGCG-BPQDs@H. No significant damage to major organs was observed in rats.

conclusionsThe obtained results demonstrated that EGCG-BPQDs@H achieved the synergistic functions of photocatalytic property, photothermal effects and promoted wound healing, and are promising multifunctional nanoplatforms for MIDBW healing in diabetics.

Indexed as

PhosphorusAnimalsBurnsCells, CulturedDiabetes Mellitus, ExperimentalHumansHuman Umbilical Vein Endothelial CellsMaleMethicillin-Resistant Staphylococcus aureusPhotochemical ProcessesPolyphenolsQuantum DotsRatsRats, Sprague-DawleyReactive Oxygen SpeciesTeaPhosphorusPolyphenolsReactive Oxygen SpeciesTeaBlack phosphorus quantum dotsDiabetic deep-burn wound healingMultifunctional nanoplatformsPhotocatalyticPhotothermal

Identifiers

PMID34758829
PMCPMC8579683
OpenAlexW3201632083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.